Alveolar Bone Loss - Why should you be concerned?

The widely prescribed Osteoperosis drug, Fosamax, has recently been connected with Alveolar bone loss.

The term alveolar bone can best be described as a thin layer of compact bone that forms the tooth socket surrounding the roots of teeth.

Fosamax has been shown to cause a condition called Osteocrenosis of the Jaw, which directly affects the alveolar bone.

This type of bone is more susceptible to osteoporosis. Studies have found relationships between systemic bone loss and increased resorption of alveolar bone.

Fosamax directly causes an increased bone resorption rate, thus effecting the bones in the area of the jaw.

If you or a loved one have experienced alveolar bone loss as a result of Fosamax, fill out the form below for a FREE Fosamax case evaluation.

Click To Talk To Us Online

Jaw Surgery

Fosamax Jaw Surgery - Fosamax risks can lead to Jaw Surgery
Fosamax dangerous risks can lead to Jaw Surgery

Biopsy

Had a biopsy to diagnose Fosamax symptoms? Learn more about Fosamax
Fosamax health risks diagnosed by biopsy - Free Fosamax Case Eval

Learn More

Learn more about Fosamax - Are you at risk? Find out here
Learn more about Fosamax - Dangerous health risks linked with Fosamax

Name

Phone

strictly confidential

Your Question

First Name
Last Name
Home Phone
Work Phone
Best Time to Call
City and State
Email
When did you start taking Fosamax?
When did you stop taking Fosamax?
How were you taking Fosamax?
What dosage were you taking?
Did you develop Osteonecrosis of the Jaw (Dead Jaw)?	Yes
How long were you taking Fosamax before you developed Osteonecrosis?
Did you have dental work done in the month before the Osteonecrosis developed?	Yes No
What type of treatment did you have?
Please describe any ongoing complications:
Additional Comments: